Nanterre, January 19th, 2026 Disclosure of transactions in on shares from January 12th to January 16th,2026 Within the framework of the authorization granted by the General Meeting of VINCI SA of April 17th, 2025, to trade in its shares and in accordance with the regulations relating to share buybacks, VINCI SA (LEI:213800WFQ334R8UXUG83) declares the purchases of treasury shares below (FR0000125486), carried out from January 12th to January 16th,2026: I - Aggregate presentation by day and by market Issue ...

Press release - Leadership change at Bottega Veneta - 20 01 2026 PRESS RELEASE January 20, 2026 KERING ANNOUNCES A LEADERSHIP CHANGE AT BOTTEGA VENETA Kering announces that Bartolomeo Rongone, Chief Executive Officer of Bottega Veneta, will be leaving the Group as of March 31, 2026, to pursue new professional opportunities. Luca de Meo, Chief Executive Officer of Kering, stated: “I would like to thank Leo Rongone for his leadership and for the significant contribution he has made to Bottega Veneta over ...

Solid Q4 2024 Bookings with an ACV of €3.25mGradual Recovery in Bookings Momentum: ACV Nearly Stable (-2.8% vs. H2 2024), After a Weaker H1 2025 (-21% vs. the Record H1 2024)Strong Revenue Growth in 2025: Up 14% at Constant Currency, Including 20% Growth in SaaS Subscriptions (Up 12% and 18%, Respectively, on a Reported Basis) Expansion in Asia-Pacific and Strengthening of Growth Levers Following the Acquisition of ezyCollectThe United States Becomes the Group’s Leading Region, Representing 30% of 2025 Reve ...

In accordance with section 30 of the Danish Capital Markets Act, we disclose that Jyske Bank today has been notified that Société Générale S.A., 29 Boulevard Haussmann, 75009 Paris, France, on 15 January 2026 held, indirectly via shares and other financial instruments with similar economic effect, 3,208,942 shares of a nominal value of DKK 10 in Jyske Bank A/S, corresponding to 5.22% of the total share capital. Yours faithfully, Jyske Bank Contact: Birger Krøgh Nielsen, CFO, tel. +45 25 26 92 42. Attachmen ...

The date for the general meeting has been changed from 19 March 2026 to 20 March 2026. The financial calendar for 2026 has therefore been revised as follows: Deadline for shareholder proposals for the AGM5 February 2026Annual report 202520 February 2026Annual general meeting 202620 March 2026Interim report Q1 20268 May 2026Interim report Q2 202627 August 2026Interim report Q3 202612 November 2026 Contact:By telephone on +45 31 21 68 72. Attachment MTHH_Company announcement 1_2026 ...

Aspo Plc ANNOUNCEMENT 20.1.2026 Aspo Plc: Share repurchase 20.1.2026 In the Helsinki Stock Exchange Trade date 20.1.2026 Bourse trade Buy Share ASPO Amount 1 000SharesAverage price/ share 7,1800EURTotal cost 7 180,00EUR Aspo Plc now holds a to ...

BOSTON, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana”), a biotechnology company developing its lead candidate, intranasal foralumab, a fully human, anti-CD3 monoclonal antibody, announces the peer-reviewed publication of its open-label study in patients with non-active secondary progressive multiple sclerosis (na-SPMS) in Neurology Neuroimmunology & Neuroinflammation, a prestigious journal of the American Academy of Neurology. The publication, titled “Nasal Foraluma ...

Core Viewpoint - Rezolve Ai has announced a registered direct offering of 62,500,000 ordinary shares at a price of $4.00 per share, aiming to raise approximately $250 million in gross proceeds before expenses [1][2]. Group 1: Offering Details - The offering is led by existing and new institutional investors and is expected to close around January 21, 2026, pending customary closing conditions [1]. - The net proceeds from the offering will be utilized for accelerated investment in the sales organization, potential mergers and acquisitions, and general corporate purposes [2]. Group 2: Financial Advisors and Agents - A.G.P./Alliance Global Partners is the lead placement agent for the offering, with Titan Partners and Maxim Group LLC as co-placement agents [2]. - Cantor Fitzgerald & Co., Roth Capital Partners, and Northland Capital Markets served as financial advisors for the offering [2]. Group 3: Regulatory Information - The offering is made under an effective shelf registration statement on Form F-3, which was declared effective by the SEC on December 19, 2025 [3]. - A prospectus supplement and accompanying prospectus will be filed with the SEC and will be available on the SEC's website [3]. Group 4: Company Overview - Rezolve Ai is a leader in AI-powered solutions, focusing on enhancing customer engagement and operational efficiency through its "Brain Suite" platform [5].

Core Insights - HII's Mission Technologies division has been awarded a 10-year, $25.4 billion contract under the Advanced Technology Support Program V (ATSP5) to provide engineering solutions for electronics and software issues [1][2]. Group 1: Contract Details - The ATSP5 contract, awarded by the Defense Microelectronics Activity, is utilized by the U.S. Department of Defense and other federal agencies for rapid access to advanced microelectronics and engineering support [2]. - The contract aims to address operational challenges due to obsolescence and expedite the deployment of advanced technologies [2]. Group 2: Company Capabilities - HII's Mission Technologies division emphasizes the importance of a reliable supply of microelectronics for enhancing warfighter survivability and mission success [3]. - The scope of ATSP5 includes hardware and software development, covering studies, analysis, design, simulation, prototyping, integration, testing, and limited production [3][4]. - HII's engineers specialize in reverse engineering and microelectronics assurance, focusing on redeploying previously obsolete systems critical to national security [4]. Group 3: Company Overview - HII is recognized as the largest military shipbuilder in the U.S., with a history of over 135 years in advancing national security [5][6]. - The company provides a wide range of capabilities, including ships, unmanned systems, cyber solutions, and artificial intelligence/machine learning technologies [6].

CHICAGO, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced continued operational growth and infrastructure expansion at Cosmofarm, its pharmaceutical distribution subsidiary in Greece. During 2025, Cosmofarm added nearly 100 new pharmacy customers, representing a weighted average increase of approximately 20% in its active customer base. This growth was accompanied by improved u ...